Nucleic acid-based approaches to STAT inhibition
Open Access
- 20 October 2012
- journal article
- review article
- Published by Taylor & Francis in JAK-STAT
- Vol. 1 (4) , 285-291
Abstract
Silencing of abnormally activated genes can be accomplished in a highly specific manner using nucleic acid based approaches. The focus of this review includes the different nucleic acid based inhibition strategies such as antisense oligodeoxynucleotides, small interfering RNA (siRNA), dominant-negative constructs, G-quartet oligonucleotides and decoy oligonucleotides, their mechanism of action and the effectiveness of these approaches to targeting the STAT (signal transducer and activator of transcription) proteins in cancer. Among the STAT proteins, especially STAT3, followed by STAT5, are the most frequently activated oncogenic STATs, which have emerged as plausible therapeutic cancer targets. Both STAT3 and STAT5 have been shown to regulate numerous oncogenic signaling pathways including proliferation, survival, angiogenesis and migration/invasion.Keywords
This publication has 72 references indexed in Scilit:
- Small Interfering RNA Targeted to IGF-IR Delays Tumor Growth and Induces Proinflammatory Cytokines in a Mouse Breast Cancer ModelPLOS ONE, 2012
- A STAT3-decoy oligonucleotide induces cell death in a human colorectal carcinoma cell line by blocking nuclear transfer of STAT3 and STAT3-bound NF-κBBMC Cell Biology, 2011
- Targeted Blockage of Signal Transducer and Activator of Transcription 5 Signaling Pathway with Decoy Oligodeoxynucleotides Suppresses Leukemic K562 Cell GrowthDNA and Cell Biology, 2011
- Down-regulation of STAT3 expression by vector-based small interfering RNA inhibits pancreatic cancer growthWorld Journal of Gastroenterology, 2011
- Targeting STAT3 in cancer: how successful are we?Expert Opinion on Investigational Drugs, 2008
- Lack of toxicity of a STAT3 decoy oligonucleotideCancer Chemotherapy and Pharmacology, 2008
- T40214/PEI complex: A potent therapeutics for prostate cancer that targets STAT3 signalingThe Prostate, 2008
- Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft miceBMC Cancer, 2007
- Advances in Preclinical Investigation of Prostate Cancer Gene TherapyMolecular Therapy, 2007
- The STATs of cancer — new molecular targets come of ageNature Reviews Cancer, 2004